Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Bac3Gel® Lda logo — Bac3Gel is a revolutionising technology to recreate in vitro...

Bac3Gel® Lda

Bac3Gel is a revolutionising technology to recreate in vitro human microbiota of different body districts.

Founded 2020 Portugal Portugal 9 employees Biotechnology, Health Care

General Information

Company Name Bac3Gel® Lda
Founded Year 2020
Location Portugal Portugal
Employees 9
Industries Biotechnology, Health Care
Social

BounceWatch is an independent company data service, not affiliated with Bac3Gel® Lda. To contact Bac3Gel® Lda, visit bac3gel.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Bac3Gel® Lda compare?

A PDF of Bac3Gel® Lda and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Bac3Gel® Lda soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Bac3Gel® Lda

Bac3Gel® Lda is a biotechnology startup based in Portugal, founded in 2020. The company's slogan, "Bac3Gel is a revolutionising technology to recreate in vitro human microbiota of different body districts," reflects its pioneering approach. Bac3Gel is centered on a game-changing technology to produce artificial mucus of various body districts in both healthy and pathological states, such as intestinal, lung, vaginal, and stomach. The technology recreates essential mucus features, including oxygen gradients, structure, viscoelastic properties, and nutrients crucial for controlling bacterial behavior and intercommunication within the human body. Bac3Gel's applications extend to recreating gut, lung, vaginal, and stomach microbiota in vitro, allowing the evaluation of the impact of therapeutic molecules such as antibiotics, nutraceuticals, probiotics, prebiotics, vitamins, and other food supplements on complex bacterial communities. This breakthrough is compatible with high-throughput screening and/or dynamic systems, offering extensive potential for various research and development applications. Moreover, Bac3Gel can be utilized to determine the permeability of therapeutic molecules through human mucus. One remarkable aspect of Bac3Gel is its fully tuneable nature, enabling modifications to culture media, DNA, proteins, lipids, and other components, tailoring its properties and structure according to specific organs and physiological or pathological scenarios. As of now, there is no publicly disclosed information regarding their last investment or the participating investors. Nonetheless, Bac3Gel's innovative technology and comprehensive potential in the healthcare sector position it as a promising player in the biotechnology space with significant prospects for future growth and impact.

Business keywords: Microbiota, Mucus Permeability, Prebiotics, Probiotics, Nutraceuticals, Antimicrobial drugs, Antibiotics, Microbiome, Personalized Medicine

No funding data available for Bac3Gel® Lda yet.

Bac3Gel® Lda Alternatives & Competitors

View All Alternatives
Bac3Gel® Lda vs
Mother Dirt
Mother Dirt United States

Restorative Skin Probiotics

Seed
1 employees
Biotechnology, Health Care
Bac3Gel® Lda vs
Exeliom Biosciences
Exeliom Biosciences France

Crossing the next frontier, to give you a fair chance to fight

Seed
8 employees
Biopharma, Biotechnology
Bac3Gel® Lda vs
Medlab Clinical Ltd
Medlab Clinical Ltd Australia

Unlocking the potential for a better life

24 employees
Biotechnology, Health Care
View all alternatives

FAQ About Bac3Gel® Lda

Bac3Gel is a revolutionising technology to recreate in vitro human microbiota of different body districts.
Bac3Gel® Lda was founded in 2020.
Bac3Gel® Lda is headquartered in Portugal.
Bac3Gel® Lda operates in Biotechnology and Health Care. Its work centres on Microbiota, Mucus Permeability, Prebiotics and Probiotics.
Bac3Gel® Lda has approximately 9 employees.
Top alternatives and competitors to Bac3Gel® Lda include Mother Dirt, Exeliom Biosciences, Medlab Clinical Ltd, The BioCollective, AceBiome. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Bac3Gel® Lda and Mother Dirt are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Bac3Gel® Lda, https://bouncewatch.com/company/bac3gel-lda, updated 5 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout